|
|
|
Volumn 21, Issue 5, 2001, Pages 22-33
|
|
Biotech manufacturing: Is the crisis real?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ALTEPLASE;
BACTERIAL PROTEIN;
BETA INTERFERON;
BETA1A INTERFERON;
EMBREL;
GENE PRODUCT;
HUMALIN;
HUMAN GROWTH HORMONE;
IMIGLUCERASE;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT FOLLITROPIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT HUMAN INSULIN;
RIBIL;
RITUXIMAB;
SOMATREM;
TRASTUZUMAB;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
VACCINE;
BIOTECHNOLOGY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
HUMAN;
PHARMACEUTICS;
REVIEW;
|
|
EID: 0035737872
PISSN: 02738139
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (10)
|
